Comment
. 2007 Jun;45(6):2093; author reply 2094.
doi: 10.1128/JCM.00412-07.
Does one voriconazole breakpoint suit all Candida species?
- PMID: 17548458
- PMCID: PMC1933056
- DOI: 10.1128/JCM.00412-07
Item in Clipboard
Comment
Does one voriconazole breakpoint suit all Candida species?
J Clin Microbiol.
2007 Jun.
No abstract available
Comment on
-
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.J Clin Microbiol. 2006 Mar;44(3):819-26. doi: 10.1128/JCM.44.3.819-826.2006. J Clin Microbiol. 2006. PMID: 16517860 Free PMC article. Clinical Trial.
Similar articles
-
A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp.Diagn Microbiol Infect Dis. 2009 Feb;63(2):233-6. doi: 10.1016/j.diagmicrobio.2008.11.001. Epub 2008 Dec 12. Diagn Microbiol Infect Dis. 2009. PMID: 19070452
-
Broth medium for microdilution susceptibility tests of fluconazole and voriconazole.Eur J Clin Microbiol Infect Dis. 2002 May;21(5):407-10. doi: 10.1007/s10096-002-0735-z. Epub 2002 May 7. Eur J Clin Microbiol Infect Dis. 2002. PMID: 12072930 No abstract available.
-
Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole.J Microbiol Immunol Infect. 2009 Apr;42(2):148-53. J Microbiol Immunol Infect. 2009. PMID: 19597647
-
Pharmacodynamic implications for use of antifungal agents.Curr Opin Pharmacol. 2007 Oct;7(5):491-7. doi: 10.1016/j.coph.2007.05.004. Epub 2007 Jul 9. Curr Opin Pharmacol. 2007. PMID: 17616480 Review.
-
Pharmacological aspects of the new triazole voriconazole.Ann Hematol. 2002;81 Suppl 2:S50-1. Ann Hematol. 2002. PMID: 12611077 Review. No abstract available.
Cited by
-
Assessment of accuracy of identification of pathogenic yeasts in microbiology laboratories in the United kingdom.J Clin Microbiol. 2012 Aug;50(8):2639-44. doi: 10.1128/JCM.00913-12. Epub 2012 May 30. J Clin Microbiol. 2012. PMID: 22649009 Free PMC article.
-
Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.J Clin Microbiol. 2011 Feb;49(2):630-7. doi: 10.1128/JCM.02161-10. Epub 2010 Dec 15. J Clin Microbiol. 2011. PMID: 21159940 Free PMC article.
-
Progress in antifungal susceptibility testing of Candida spp. by use of Clinical and Laboratory Standards Institute broth microdilution methods, 2010 to 2012.J Clin Microbiol. 2012 Sep;50(9):2846-56. doi: 10.1128/JCM.00937-12. Epub 2012 Jun 27. J Clin Microbiol. 2012. PMID: 22740712 Free PMC article. Review.
-
Validation of 24-hour posaconazole and voriconazole MIC readings versus the CLSI 48-hour broth microdilution reference method: application of epidemiological cutoff values to results from a global Candida antifungal surveillance program.J Clin Microbiol. 2011 Apr;49(4):1274-9. doi: 10.1128/JCM.02437-10. Epub 2011 Feb 2. J Clin Microbiol. 2011. PMID: 21289155 Free PMC article.
-
Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.J Clin Microbiol. 2013 Aug;51(8):2571-81. doi: 10.1128/JCM.00308-13. Epub 2013 May 29. J Clin Microbiol. 2013. PMID: 23720791 Free PMC article.
References
-
- Arendrup, M., T. Horn, and N. Frimodt-Moller. 2002. In vivo pathogenicity of eight medically relevant Candida species in an animal model. Infection 30:286-291. - PubMed
-
- Arendrup, M. C., K. Fuursted, B. Gahrn-Hansen, I. M. Jensen, J. D. Knudsen, B. Lundgren, H. C. Schønheyder, and M. Tvede. 2005. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility. J. Clin. Microbiol. 43:4434-4440. - PMC - PubMed
-
- Boyd, A. E., S. Modi, S. J. Howard, C. B. Moore, B. G. Keevil, and D. W. Denning. 2004. Adverse reactions to voriconazole. Clin. Infect. Dis. 39:1241-1244. - PubMed
-
- Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
